Abstract:As the current understanding of COVID-19 continues to evolve, a synthesis of the literature on the neurological impact of this novel virus may help inform clinical management and highlight potentially important avenues of investigation. Additionally, understanding the potential mechanisms of neurologic injury may guide efforts to better detect and ameliorate these complications. In this review, we synthesize a range of clinical observations and initial case series describing potential neurologic manifestations of COVID-19 and place these observations in the context of coronavirus neuro-pathophysiology as it may relate to SARS-CoV-2 infection. Reported nervous system manifestations range from anosmia and ageusia, to cerebral hemorrhage and infarction. While the volume of COVID-19-related case studies continues to grow, previous work examining related viruses suggests potential mechanisms through which the novel coronavirus may impact the CNS and result in neurological complications. Namely, animal studies examining the SARS-CoV have implicated the angiotensin-converting-enzyme-2 receptor as a mediator of coronavirus-related neuronal damage and have shown that SARS-CoV can infect cerebrovascular endothelium and brain parenchyma, the latter predominantly in the medial temporal lobe, resulting in apoptosis and necrosis. Human postmortem brain studies indicate that human coronavirus variants and SARS-CoV can infect neurons and glia, implying SARS-CoV-2 may have similar neurovirulence. Additionally, studies have demonstrated an increase in cytokine serum levels as a result of SARS-CoV infection, consistent with the notion that cytokine overproduction and toxicity may be a relevant potential mechanism of neurologic injury, paralleling a known pathway of pulmonary injury. We also discuss evidence that suggests that SARS-CoV-2 may be a vasculotropic and neurotropic virus. Early reports suggest COVID-19 may be associated with severe neurologic complications, and several plausible mechanisms exist to account for these observations. A heightened awareness of the potential for neurologic involvement and further investigation into the relevant pathophysiology will be necessary to understand and ultimately mitigate SARS-CoV-2-associated neurologic injury.

Neurological Complications of COVID-19 and Possible Neuroinvasion Pathways: A Systematic Review

Neurological and Psychiatric Presentations Associated with COVID-19

Neurological Involvement in COVID-19 and Potential Mechanisms: A Review

Neurological Complications of COVID-19: Unraveling the Pathophysiological Underpinnings and Therapeutic Implications

Neurological Complications of COVID-19 Infection: A Comprehensive Review

The Neurological Implications of COVID-19: A Comprehensive Narrative Review

Neurological complications caused by SARS-CoV-2

Neurologic aspects of covid-19: a concise review

Neurological complications and infection mechanism of SARS-CoV-2

Neurological Complications of COVID-19: A Systematic Review of Literature

Neurological Manifestations of COVID-19 (SARS-CoV-2): A Review

COVID-19 and Central Nervous System Manifestations: A Systemic review on Therapeutic Outcome

COVID-19: Neuroinvasiveness, Neurotropism and Neurovirulence

A Systematic Review Unraveling the Intricate Neurological Spectrum of COVID-19: Manifestations, Complications, and Transformative Insights for Patient Care

Possible mechanism of central nervous system targeting and neurological symptoms of the new-coronavirus (COVID-19): literature review

Crosstalk between SARS-CoV-2 Infection and Neurological Disorders: A Review.

SARS-CoV-2 Infection in the Central and Peripheral Nervous System-Associated Morbidities and Their Potential Mechanism

Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions

Experimental Models of SARS-COV-2 Infection in the Central Nervous System

Neurological Manifestations of Patients with COVID-19: Potential Routes of SARS-CoV-2 Neuroinvasion from the Periphery to the Brain

Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19)